4.2 Article

Variation of anti-Fas antibodies in different lots of intravenous immunoglobulin

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death

M. Schulte et al.

CELL DEATH AND DIFFERENTIATION (2007)

Review Pharmacology & Pharmacy

Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders

Hakan M. Gurcan et al.

ANNALS OF PHARMACOTHERAPY (2007)

Article Allergy

Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies

Stephan von Gunten et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)

Article Immunology

The antiinflammatory activity of IgG: the intravenous IgG paradox

Falk Nimmerjahn et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2007)

Review Allergy

Toward molecular targeting with specific intravenous immunoglobulin preparation

M Blank et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2005)

Review Allergy

Facing the enigma of immunomodulatory effects of intravenous immunoglobulin

T Sapir et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2005)

Article Allergy

Concurrent presence of agonistic and antagonistic anti-CD95 autoantibodies in intravenous Ig preparations

F Altznauer et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)

Review Biochemistry & Molecular Biology

Protein-based therapeutic approaches targeting death receptors

LE French et al.

CELL DEATH AND DIFFERENTIATION (2003)

Review Medicine, General & Internal

Advances in immunology: Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.

MD Kazatchkine et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)